Search company, investor...


Leukosite has not claimed their Profile.

Want to better differentiate Leukosite between your competitors? Show buyers how.

Leukosite Logo

Why does Leukosite win vs. CoImmune?

Show Leukosite's primary competitive advantage
Show Leukosite's competitive differentiation

Leukosite's alternatives and competitors

See how Leukosite compares to similar products. Leukosite's top competitors include CoImmune, Actinobac Biomed, and Altor BioScience.

CoImmune Logo

CoImmune, fka Argos Therapeutics, is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatmen…

Leukosite vs. CoImmune

View more in-depth data on:

  • Competitors
  • Products
  • Customer References and more

Compete with Leukosite?

Brief our analysts.

Get in front of tech buyers.

100% free.

No pay-to-play nonsense.

Compare Leukosite to Competitors

Can-Fite BioPharma Logo
Can-Fite BioPharma

Can-Fite BioPharma is a biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities.

AnaMar Medical

AnaMar Medical is a company in the field of cartilage biology and associated joint diseases. The company has an project portfolio with five drugs and one biomarker in development and two biomarkers on the market.

Virdante Pharmaceuticals

Virdante Pharmaceuticals is developing safer and more effective drugs for autoimmune and inflammatory diseases. The company's products incorporate a proprietary sialic switch technology to improve the anti-inflammatory properties of antibodies.

Y's Therapeutics

Y's Therapeutics focuses on developing monoclonal antibody therapies and other molecular-targeted biological drugs for the treatment of inflammation-mediated diseases, cancer, and other unmet medical needs. The company also have small molecule compounds in the company's R&D pipeline to diversify the company's portfolio.


MuriGen is building a portfolio of drugs for unmet medical needs across a number of therapeutic areas including cancer, arthritis, thrombocytopenia, inflammation, epilepsy and thalassemia.


PROTEOLOGICS develops a class of drugs for viral and other ubiquitin-mediated diseases utilizing technology and knowledge of the ubiquitin system.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.